Quick Answer
Sagimet Biosciences Inc. reported Total Assets of $116.48 million for the year ending 2025.
- Sagimet Biosciences Inc. showed a decrease of -27.3% in Total Assets from 2024 to 2025.
- This data is from Sagimet Biosciences Inc.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2023: $21.50 million | Q3 2023: $102.93 million | Q1 2024: $194.53 million | Q2 2024: $189.02 million | Q3 2024: $174.78 million | Q1 2025: $146.17 million | Q2 2025: $137.41 million | Q3 2025: $128.40 million.
- Over the full 4 years of available data (2022 to 2025), Sagimet Biosciences Inc.'s Total Assets has grown by 252.6%.
- Historical annual values: Fiscal year 2025: $116.48 million | Fiscal year 2024: $160.26 million | Fiscal year 2023: $96.72 million | Fiscal year 2022: $33.03 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: